SMMT — SUMMIT THERAPEUTICS INC

Ownership history in XTX Topco Ltd  ·  5 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in SUMMIT THERAPEUTICS INC (SMMT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2025 Q2)
Avg. % of fund
0.02%
First filed
2023 Q1
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 14,535 -28,913 -66.5% 0.02% $300K $20.66
2025 Q2 ADDED 43,448 +19,533 +81.7% 0.04% $925K $21.28
2024 Q3 ADDED 23,915 +8,415 +54.3% 0.04% $524K $21.90
2024 Q2 REDUCED 15,500 -11,513 -42.6% 0.01% $121K $7.80
2023 Q1 INITIATED 27,013 — — 0.01% $47K $1.75
% of Fund (quarterly)    SMMT price (monthly, adj. close)

Other funds also holding SMMT

As of 2025 Q4 — sorted by position size

APEIRON CAPITAL Ltd 3Y 26.48% BAKER BROS. ADVISORS LP 3Y 7Y 3.73% Polymer Capital Management (HK) LTD 3.54% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 1.12% Rock Springs Capital Management LP 3Y 7Y 0.64% QVT Financial LP 3Y 7Y 0.54% Capstone Capital Management Ltd 0.47% GRIFFIN ASSET MANAGEMENT, INC. 3Y 7Y 0.37% Affinity Asset Advisors, LLC 3Y 0.35% AXQ CAPITAL, LP 3Y 0.32%
← Back to XTX Topco Ltd Holdings